Chicago Capital LLC Has $797,000 Stock Position in CME Group Inc. (NASDAQ:CME)

Chicago Capital LLC raised its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 111.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,006 shares of the financial services provider's stock after acquiring an additional 1,583 shares during the quarter. Chicago Capital LLC's holdings in CME Group were worth $797,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CME. New Age Alpha Advisors LLC lifted its stake in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 43 shares during the period. Knuff & Co LLC bought a new stake in CME Group during the 4th quarter worth about $33,000. Banque Transatlantique SA acquired a new position in CME Group during the 4th quarter valued at about $35,000. Whipplewood Advisors LLC acquired a new position in CME Group during the 4th quarter valued at about $37,000. Finally, United Community Bank bought a new position in shares of CME Group in the 4th quarter valued at about $37,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Activity at CME Group

In other CME Group news, Director Dennis Suskind sold 1,000 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the transaction, the director now owns 2,915 shares in the company, valued at approximately $790,781.20. This represents a 25.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the sale, the director now directly owns 5,400 shares in the company, valued at $1,471,824. This represents a 35.71% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is owned by company insiders.

CME Group Price Performance

Shares of CME stock opened at $269.70 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $290.79. The firm has a fifty day moving average of $273.29 and a 200-day moving average of $254.82. The firm has a market capitalization of $97.19 billion, a price-to-earnings ratio of 27.13, a price-to-earnings-growth ratio of 3.63 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the company posted $2.50 earnings per share. The company's revenue for the quarter was up 10.4% on a year-over-year basis. On average, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.85%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.

Analysts Set New Price Targets

CME has been the subject of a number of recent research reports. Raymond James Financial raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target for the company in a research note on Monday, March 10th. Bank of America lifted their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods increased their price target on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research note on Thursday, April 24th. Royal Bank Of Canada restated a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Finally, Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $258.20.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.